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The cell wall of Mycobacterium tuberculosis has a complex
ultrastructure that consists of mycolic acids connected to pepti-
doglycan via arabinogalactan (AG) and abbreviated as the mAGP
complex. ThemAGP complex is crucial for the survival and path-
ogenicity of M. tuberculosis and is the target of several anti-tu-
bercular agents. Apart from sharing a similar mAGP and the
availability of the complete genome sequence, Corynebacterium
glutamicum has proven useful in the study of orthologous M.
tuberculosis genes essential for viability. Here we examined the
effects of particular genes involved in AG polymerization by gene
deletion in C. glutamicum. The anti-tuberculosis drug ethambu-
tol is thought to target a set of arabinofuranosyltransferases
(Emb) that are involved in arabinan polymerization. Deletion of
emb in C. glutamicum results in a slow growing mutant with
profound morphological changes. Chemical analysis revealed a
dramatic reduction of arabinose resulting in a novel truncated
AG structure possessing only terminal arabinofuranoside
(t-Araf) residues with a corresponding loss of cell wall bound
mycolic acids. Treatment of wild-type C. glutamicum with
ethambutol and subsequent cell wall analyses resulted in an
identical phenotype comparable to the C. glutamicum emb dele-
tion mutant. Additionally, disruption of ubiA in C. glutamicum,
the first enzyme involved in the biosynthesis of the sugar donor
decaprenol phosphoarabinose (DPA), resulted in a complete loss
of cell wall arabinan. Herein, we establish for the first time, (i)
that in contrast toM. tuberculosis embA and embBmutants, dele-
tion of C. glutamicum emb leads to a highly truncated AG pos-
sessing t-Araf residues, (ii) the exact site of attachment of arabi-
nan chains in AG, and (iii) DPA is the only Araf sugar donor
in AG biosynthesis suggesting the presence of a novel enzyme
responsible for “priming” the galactan domain for further elab-
oration by Emb, resulting in the final maturation of the native
AG polysaccharide.
The Corynebacterianeae represent a distinct and unusual group
within Gram-positive bacteria, with the most prominent members
being the human pathogensMycobacterium tuberculosis andMycobac-
terium leprae (1). In addition, the human pathogen Corynebacterium
diphtheriae is the causal agent of diphtheria, and serious economic
losses occur from the infection of animals by corynebacterial strains,
such as Corynebacterium pseudotuberculosis and Corynebacterium
matruchotii (2, 3). Furthermore, non-pathogenic bacteria belong to this
taxon, such as Corynebacterium glutamicum, which is used in the
industrial production of amino acids (4). A common feature to all these
bacteria is that they possess an unusual cell wall matrix composed of
mycolic acids, arabinogalactan, and peptidoglycan and is often referred
to as the mycolyl-arabinogalactan-peptidoglycan (mAGP)6 complex
(5–9).
Arabinogalactan (AG) plays a crucial role in covalently anchoring the
outer lipid layer to peptidoglycan. Synthesis of AG begins with the for-
mation of the linker unit through the transfer of GlcNAc-1-P and Rha
from their respective sugar nucleotides (UDP-GlcNAc and dTDP-Rha)
to form polyprenol-P-P-GlcNAc and polyprenol-P-P-GlcNAc-Rha
lipid intermediates (10, 11). The intermediates polyprenol-P-P-GlcNAc
and polyprenol-P-P-GlcNAc-Rha then serve as acceptors for the
sequential addition of galactofuranose (Galf) residues from UDP-Galf
(generated from UDP-Galp via Glf (12, 13)) to form polyprenol-P-P-
GlcNAc-Rha-Gal30 through a novel enzymedesignatedGlfT (Rv3808c).
This latter enzyme expresses two glycosyltransferase activities, a UDP-
Galf:-D-(135)-Galf and a UDP-Galf:-D-(136)-Galf, both activities
being required for alternating (135) and (136) linkages during
galactan polymerization (11, 14). Chemical analysis of the mature lipid-
linked galactan, synthesized in vitro (11), suggests that this intermediate
then serves as the acceptor for the subsequent addition of arabino-
furanose (Araf) residues from the arabinose sugar donor -D-arabino-
furanosyl-1-monophosphoryldecaprenol (DPA) in the formation of the
Araf portion (135, 133, and 132 linkages) of AG (15–18). The
AG-lipid intermediate at some point is mycolylated and transglycosy-
lated to peptidoglycan (19, 20).
Early studies demonstrated that administration of ethambutol (EMB)
led to a rapid cessation of mycolic acid transfer to the cell wall and an
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accumulation of trehalose monomycolate and trehalose dimycolate
(21). Subsequently, EMB was shown to inhibit specifically AG biosyn-
thesis (22). The precisemolecular target of EMB occupies the emb locus
in Mycobacterium avium and M. tuberculosis. The locus consists of
embRAB in M. avium (23) and embCAB in M. tuberculosis (24). To
further define the role of EmbCAB proteins in arabinan biosynthesis,
embA, embB, and embC genes were inactivated individually in Myco-
bacterium smegmatis (25, 26). Although all three mutants were viable,
only the crucial terminal Ara6 motif, which is the template for mycoly-
lation in AG, was altered in both embA and embB mutants with the
remainingAG structure intact (25). This suggested that both EmbA and
EmbB are involved in the formation of the terminal Ara6 motif in AG,
and EmbC in the formation of arabinan in lipoarabinomannan (26). Our
preliminary attempts to obtain deletion mutants of embA and embB in
M. tuberculosis or embAB inM. smegmatis have proved unsuccessful,7
presumably due to the essentiality of cell wall mAGP (27–29).
In the present study we have established through comparative
genomic analyses the first biochemical and molecular description of
compete ablation of cell wall arabinan biosynthesis in a non-mycobac-
terial spp., andwehighlight the inherent usefulness of examining related
spp. to probe complex biosynthetic pathways.
MATERIALS ANDMETHODS
Strains and Culture Conditions—C. glutamicum ATCC 13032 (the
wild-type strain, and referred for the remainder of the text asC. glutami-
cum) and Escherichia coli DH5mcr were grown in Luria-Bertani (LB)
broth (Difco) at 30 °C and 37 °C, respectively. Themutants generated in
this study were grown on BHIS (5 g of Tryptone, 5 g of NaCl, 2.5 g of
yeast extract, 18.5 g of brain heart infusion (Difco), and 90.1 g of sorbitol
per liter). Kanamycin and ampicillin were used at a concentration of 50
g/ml. The minimal medium CGXII was used for C. glutamicum (30).
Samples for lipid analyses were prepared by harvesting cells at an optical
density (OD) of 10–15, followed by a saline wash and freeze drying.
Cultivation of C. glutamicumemb for lipid and cell wall analysis
required two pre-cultures: Firstly, a 5-ml BHIS culture was grown for
8 h, whichwas then used to inoculate a 50-ml BHIS culture for 15 h. This
was then used to inoculate a 100-ml BHIS culture to OD 1, which was
harvested after reaching an OD 3.
Construction of Plasmids—The vectors used for deletion and inacti-
vation were as follows: pK19mobsacBemb (NCgl0184, embC),
pCg::ubiA (NCgl2781, Rv3806c), with the gene numbers of the C. glu-
tamicum andM. tuberculosis orthologs added in parentheses. The plas-
mid used for overexpression was pEKEx2emb. To enable deletion of
gene cross-over PCR was applied to generate the fragments carrying
fused sequences adjacent to the gene in question. The resulting frag-
ments were ligated with pK19mobsacB, and the final plasmids were
confirmed by sequencing. For emb deletion, the primers used were
emb_start_in 5-CCCATCCACTAAACTTAAACACTCAACTAC
ATC TGA CAC GTT GAT C-3, emb_start_out 5-GCT TGG TGA
GTT CGG AAA CAG GA-3, emb_end_in 5-TGT TTA AGT TTA
GTG GAT GGG CTC TGG AAT CCA GGG CAT ATG AAG-3, and
emb_end_out 5-TTCCATGAGCAGCTGGCGATAAC-3. For the
second PCR the primer pair emb_start_out and emb_end_out was used
again. The resulting fragment was ligated with SmaI-cleaved
pK19mobsacB to generate pK19mobsacBemb. For inactivation of
ubiA an internal fragment of 321 bp was amplified (pubiA-for: ATC
TTC AAC CAG CGC ACG ATC; pubiA-rev: AAT ATC GAT CAC
TGGCATGTGC),whichwasmade blunt and ligated into the SmaI site
of the non-replicative vector pK18mob to yield pCg::ubiA.
Genomic Mutations—To enable chromosomal inactivation of ubiA,
pCg::ubiA was introduced into C. glutamicum by electroporation.
Selection for resistance to kanamycin yielded clones whose correct dis-
ruption of ubiA was confirmed with different primer pairs annealing in
the vector and the bacterial chromosome.
Southern Blot Analysis—Genomic DNA was extracted from
C. glutamicumemb and the wild-type strain and cleaved with
EcoRV. The resulting fragments were separated on a 1% agarose gel
and blotted onto a Nytran NY13N nitrocellulose membrane, with
subsequent washings according to standard protocols. Detection
was carried out with a fragment generated by PCR with primers
pEmb1 (5-GTG GTT TAG GGG GTC TGT TGG G-3) and
pEmb2 (5-GGC AGC GTG CCG ATC ATC GCC-3) as probe
that was labeled with digoxigenin (DIG labeling and detection kit,
Roche Applied Science).
Extraction and Analysis of Cell Wall Bound Mycolic Acids from
C. glutamicum Strains—Cells were grown as described above, harvested,
washed, and freeze-dried.Cells (100mg)wereextractedby twoconsecutive
extractionswith 2ml ofCHCl3/CH3OH/H2O (10:10:3, v/v) for 3 h at 50 °C.
The bound lipids from the delipidated extracts or purified cell walls (see
below) were released by the addition of 2 ml of 5% aqueous solution of
tetrabutylammonium hydroxide, followed by overnight incubation at
100 °C. After cooling, water (2 ml), CH2Cl2 (4 ml), and CH3I (500l) were
added and mixed thoroughly for 30 min. The lower organic phase was
recovered following centrifugation and washed three times with water
(4 ml), dried, and resuspended in diethyl ether (4 ml). After centrifugation
the clear supernatant was again dried and resuspended in CH2Cl2 (100l).
An aliquot (10 l) from each strain was subjected to TLC using silica gel
plates (5735 silica gel 60F254, Merck), and developed in petroleum ether/
acetone (95:5, v/v) and charred using 5%molybdophosphoric acid in etha-
nol at 100 °C to reveal corynomycolic acid methyl esters (CMAMES) and
compared with known standards (31).
Isolation of the mAGP Complex—The thawed bacterial cells were
resuspended in phosphate-buffered saline containing 2% Triton
X-100 (pH 7.2), disrupted by sonication and centrifuged at 27,000
g (6, 7). The pelleted material was extracted three times with 2% SDS
in phosphate-buffered saline at 95 °C for 1 h to remove associated
proteins, successively washed with water, 80% (v/v) acetone in water,
and acetone, and finally lyophilized to yield a highly purified cell wall
preparation (6, 7).
Glycosyl Composition of Cell Walls by Alditol Acetates—Cell wall
preparations were hydrolyzed in 250 l of 2 M trifluoroacetic acid at
120 °C for 2 h as described (6, 7). Sugar residues were reducedwith 50l
of NaB2H4 (10 mg/ml in ethanol:1 M NH3 (1:1)), and the resultant aldi-
tols were per-O-acetylated and examined by gas chromatography (GC)
as described previously (6, 7).
Glycosyl Linkage Analysis of Cell Walls—Cell wall preparations (10
mg) were suspended in 0.5 ml of Me2SO (anhydrous) and 100 l of 4.8
M dimethyl sulfinyl carbanion (6, 7). The reaction mixture was stirred
for 1 h, and then CH3I was slowly added, and the suspension was stirred
for a further 1 h; this process was repeated for a total of three times. The
reaction mixture was then diluted with an equal volume of water, and
the entire contents were dialyzed against water overnight. The resulting
per-O-methylated cell wall samples were applied to a C18 Sep-Pak car-
tridge and purified as described previously (6, 7). The per-O-methylated
cell walls were hydrolyzed using 250 l of 2 M trifluoroacetic acid at
120 °C for 2 h. The resulting hydrolysate was reduced with NaB2H4,
per-O-acetylated, and examined by gas chromatography/mass spec-
trometry (GC/MS) as described previously (6, 7).
Mass Spectrometry of Per-O-methylated Cell Walls—Per-O-methyl-
ated cell walls were prepared as described above. Methanolic-HCl was7 W. N. Maughan, unpublished results.
Arabinan-deficient Mutants of C. glutamicum
SEPTEMBER 16, 2005•VOLUME 280•NUMBER 37 JOURNAL OF BIOLOGICAL CHEMISTRY 32363
 at R
sch Cntr Julich Res library on August 6, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
prepared by bubbling HCl gas into 2 ml of methanol until hot to the
touch (1 molar). The reagent (100 l) was added to the per-O-meth-
ylated cell wall sample, and aliquots were analyzed by matrix-assisted
laser desorption/ionization-time of flight mass spectrometry (MALDI-
TOFMS) tomonitor hydrolysis. The reaction was terminated by drying
under nitrogen. MALDI-MS was performed using a PerSeptive Biosys-
tems Voyager DETM STRmass spectrometer (Applied Biosystems, CA)
in the reflectron mode with delayed extraction. Samples were dissolved
in methanol, and 1-l aliquots were loaded onto a metal plate with 1 l
of the matrix 2,5-dihydrobenzoic acid. Sequazyme peptide mass stand-
ards were used as external calibrants (Applied Biosystems, CA).
GC and GC/MS of Sugar Composition and Sugar Linkage Analysis—
Analysis of alditol acetate sugar derivatives was performed on a CE
Instruments ThermoQuest Trace GC 2000. Samples were injected in
the splitless mode. The column used was a DB225 (Supelco). The oven
was programmed to hold at an isothermal temperature of 275 °C for a
run time of 15 min. GC/MSwas carried out on a Finnigan Polaris/GCQ
PlusTM. The column used was a BPX5 (Supelco).
RESULTS
Genome Comparison of the emb Locus—M. tuberculosis, M. bovis,
M. leprae, andM. avium subsp. paratuberculosis have three emb genes
(Fig. 1A), and at least one of these, embB, is suggested to be the target of
EMB in mycobacteria (24, 32–34). However, C. diphtheriae and C. glu-
tamicum have only one emb gene (35, 36). This is in accordancewith the
notion that the genome of Corynebacterium is considered to represent
the archetype of Corynebacterianeae and has a low frequency of struc-
tural alterations and gene duplications (37). Interestingly, the single emb
of C. glutamicum, Cg-emb, exhibits a higher identity to embC than to
embA and embB ofMycobacterium, and increased expression ofCg-emb
increases resistance of C. glutamicum toward EMB (38). In M. leprae
and M. avium spp. paratuberculosis the paralogous embAB genes are
separated by divergently transcribed genes that might indicate a more
specific function and a separate regulation in these mycobacteria.
The above genomic comparison and the availability of the complete
genome sequence of C. glutamicum has proven useful in the study of
orthologousM. tuberculosis genes that are essential for viability. There-
fore, in this study we examined the effects, in terms of arabinan biosyn-
thesis and utilization of the sugar donor DPA, of firstly, Cg-emb by gene
deletion in C. glutamicum, and secondly, disruption of Cg-ubiA (Fig.
1B), an enzyme recently shown to be involved in the biosynthesis of the
sugar donor DPA.
Construction of C. glutamicumemb—In our recent studies on emb
ofC. glutamicumweplaced the chromosomally encoded gene under the
control of a tetracycline repressor (38) and observed a number of phys-
iological consequences, including reduced growth in presence of
repressor (38). These studies encouraged us to test whether it would be
possible to obtain a deletion of emb in C. glutamicum. The non-repli-
cative plasmid pk19mobsacBembwas constructed carrying sequences
adjacent to emb. The vector was introduced into C. glutamicum and in
several electroporation assays 3 kanamycin resistance clones were
obtained, indicating integration of pk19mobsacBemb into the genome
by homologous recombination (Fig. 2, A and B). The sacB gene enables
for positive selection of a second homologous recombination event that
can result either in the originalwild-type situation or in clones deleted of
emb. More than 200 clones were obtained after 2–4 days and analyzed
by PCR, but in all of them the wild-type situation was restored, illustrat-
ing a strong disadvantage of emb deletion. Only 3 clones appearing after
10 dayswere shownby PCR to have emb deleted. A further confirmation
of emb deletion in one of the clones chosen was obtained in a Southern
blot analysis (Fig. 2C). The chromosomal EcoRV fragment of the wild-
type is 7.82 kb in size, whereas that of the emb deletion mutant is
reduced to 4.35 kb, which mirrors the absence of emb of 3,438 bp. This
confirms the integrity of the gene locus in the emb deletion mutant.
In Vitro Growth Analysis of C. glutamicumemb—The deletion
mutant was transformedwith pEKEx2emb (38), and growthwas studied
on brain-heart-infusion media supplemented with sorbitol for osmotic
stabilization (30). Whereas growth of C. glutamicum was completed
after 8 h at an OD of 16, C. glutamicumemb hardly reached an OD of
2 (Fig. 2D). However, complementation of the deletion mutant with
pEKEx2emb restored the wild-type growth phenotype. mRNA tran-
script quantifications using LightCycler technology confirmed a 5-fold
overexpression of emb due to pEKEx2emb when comparing expression
of emb with its chromosomal copy (data not shown). M. tuberculosis
FIGURE 1. Comparison of themycolylarabinogalactan locuswithin the Corynebacterianeae. A, the locus consists of embCwith its upstreamgene. B, the ten genes delimited by
glfT and accD4. The open reading frames of M. tuberculosis shown in panel A cover the genome sequence from nucleotide 4,235,265 to 4,251,005, and in panel B from nucleotide
4,254,380 to 4,274,593, they are separated by fadE35 and a transposase (not shown).M. avium p.,M. avium subp. paratuberculosis.
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embC, embA, and embB were cloned into pEKE2, however, although
expression and sequence integrity of each clone was confirmed, no
complementation of C. glutamicumemb was achieved (data not
shown). Analysis by lightmicroscopy and electronmicrographs showed
that when compared with C. glutamicum, C. glutamicumemb exhib-
ited profound morphological changes similar to that of C. glutamicum
treated with 100 g/ml EMB (38) (data not shown).
Lipid Characterization of Mutants—To relate the phenotypic
changes of the C. glutamicumembmutant to its cellular composition,
the C. glutamicumemb and its Cg-emb complemented strain along
with C. glutamicum were analyzed for arabinogalactan-esterified
corynomycolic acids. Bound lipids were analyzed by hydrolysis and the
preparation of corynomycolic acid methyl esters (CMAMES). The
profile of the extracted CMAMES is shown in Fig. 3. In the C. glu-
tamicumembmutant, cell wall-bound corynomycolic acidswere com-
pletely absent. The complementation of this strain with Cg-emb led to a
restoration of cell wall-bound corynomycolic acids. These results sug-
gest that Cg-emb is involved in arabinan biosynthesis of AG whereby
deletion removes the sites of mycolylation (8).
Glycosyl Compositional Analysis of Cell Walls from C. glutamicum,
C. glutamicumemb, and Cg-emb-complemented C. glutamicumemb—
GC analysis of alditol acetates prepared from C. glutamicum cell walls
(Fig. 4) reveals the presence of rhamnose (Rha), arabinose and galactose
(Gal), respectively. Analysis of M. tuberculosis AG sugar composition
shows that there are subtle differences when comparedwithC. glutami-
cum, with relatively reduced amounts of Rha (data not shown) (6, 7).
Analysis of alditol acetates prepared fromC. glutamicumemb depicts a
situationwith a dramatically reduced (90%), but not complete absence
of arabinose content in the cell wall. It is also interesting to note that the
relative amount of Rha is also reduced in this mutant. These results
suggest that the presence of a high proportion of Rha in the cell walls of
C. glutamicum is located or associated to the arabinan domains of the
cell wall AG. Overall, these phenotypes are also observed upon treat-
ment of C. glutamicum with 100 g/ml of the anti-mycobacterial drug
EMB (data not shown). Complementation of the embmutant with plas-
givenashatchedboxes inpanelsAandB.C, final confirmationof theconstructed strainvia
Southern blot analysis using chromosomal DNA from C. glutamicumemb (lane 1), and
Cg-WT (C. glutamicum) (lane 2). The right lane contains standardswith their sizes given in
kilobases. The left lane gives the sizes of the EcoRV fragments obtained from the wild-
type, and the emb deletion mutant. The calculated sizes were 7.82 kb for the wild-type,
and 4.35 kb for the deletion mutant. D, consequences of emb deletion on growth of
C. glutamicum (f), C. glutamicum deleted of emb (C. glutamicumemb,Œ), as well as the
same strain expressing plasmid encoded emb (C. glutamicumemb pEKEx2emb ().
FIGURE 2. Construction of C. glutamicumembmutant and growth analysis. A, illus-
trated is embwith its adjacentgenesofunknown functionand the strategy todelete emb
using thedeletionvectorpK19mobsacBemb. Thedeletionvector carries 12nucleotides
of the 5-end of emb and 12 nucleotides of its 3-end thereby enabling the in-frame
deletion of almost the entire embgene. The hatched small box locates the probe used for
the Southern blot analysis to detect hybridizing sequences on the 7.82-kb EcoRV frag-
ment of the wild-type containing emb. Distances are not drawn to scale. B, situation
of the original emb locus after deletion of emb, showing the intact organization of
the originally adjacent genes inC. glutamicumembwith the digoxigenin-labeledprobe
FIGURE 3. Analysis of cell wall bound CMAMES from delipidated cells of C. glutami-
cum, C. glutamicumemb, and C. glutamicumemb pEKEx2emb. Lane 1, C. glutami-
cum; lane 2,C. glutamicumemb; and lane 3,C. glutamicumembpEKEx2emb.Thebound
corynomycolic acids from the delipidated extracts or purified cell walls were released by
the addition of tetrabutylammonium hydroxide at 100 °C overnight and methylated as
described under “Materials and Methods.” An aliquot from each strain was subjected to
TLC using silica gel plates (5735 Silica Gel 60F254, Merck), and developed in petroleum
ether/acetone (95:5, v/v) and charred using 5% molybdophosphoric acid in ethanol at
100 °C to reveal CMAMES and compared with known standards (31).
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FIGURE 4. Glycosyl compositional analysis of cell walls of C. glutamicum, C. glutamicumemb, and C. glutamicumemb pEKEx2emb. Samples of purified cell walls were
hydrolyzedwith 2 M trifluoroacetic acid, reduced, per-O-acetylated, and subjected to GC as described under “Materials andMethods.” Alditol acetate standards (Supelco) of Rha, Ara,
and Gal were analyzed with retention times of 6, 7, and 10.1 min, respectively.
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mid-encoded Cg-emb restored the glycosyl composition to that of
C. glutamicum (Fig. 4).
Glycosyl Linkage Analysis of Cell Walls from C. glutamicum, C. glu-
tamicumemb, and Cg-emb-complemented C. glutamicumemb—
Per-O-methylated alditol acetate derivatives of C. glutamicum,
C. glutamicumemb, and C. glutamicumemb complemented with
plasmid-encoded emb are shown in Fig. 5. Glycosyl linkages present in
M. tuberculosis (data not shown) and C. glutamicum include t-Araf,
2-Araf, 5-Araf, 4-Rhap, t-Galf, 3,5-Araf, 5-Galf, 6-Galf, and 5,6-Galf. The
major difference between C. glutamicum and M. tuberculosis AG
includes the presence of 2,5-Araf and t-Rhap residues inC. glutamicum.
InC. glutamicumemb a loss of 5-Araf, 3,5-Araf, 2,5-Araf, and t-Rhap is
observed with only t-Araf residues appearing alongside 5-Galf, 6-Galf,
and 5,6-Galf residues. These results suggest that Cg-Emb actually plays
a much larger role in the arabinosylation of AG in comparison to the
results previously obtained with M. smegmatis EmbA and EmbB
mutants (25), possibly suggesting some partial complementation of
EmbA and EmbB in the singularM. smegmatis emb disruption mutants
(25). In addition, the AG of C. glutamicum is unusual in that it would
appear that the arabinan domains are also capped by t-Rhap residues,
because these are absent in the C. glutamicumemb mutant. Comple-
mentation of the emb mutant with plasmid-encoded Cg-emb restored
the glycosyl linkage profile to that of C. glutamicum. Glycosyl linkage
analysis of C. glutamicum treated with 100 g/ml of EMB yielded a
CG/MS trace comparable to that of C. glutamicumemb (data not
shown).
MALDI MS Analysis of Per-O-methylated Cell Walls from C. glu-
tamicumemb—Cell walls derived fromC. glutamicumembwere per-
O-methylated and analyzed by MALDI-TOF MS, and the data are
shown in Fig. 6A. The cluster of signals aroundm/z 4000 can be attrib-
uted to an AG polymer with truncated arabinan branching. The signals
at m/z 3375, 3783, 4191, and 4599 are consistent with an AG glycan
containingincreasingnumbersofGalresidues,Ara3Gal13Rha,Ara3Gal15-
Rha, Ara3Gal17Rha, and Ara3Gal19Rha, respectively. The additional sig-
nals observed can be assigned to AG glycans lacking an Ara or Rha
residue, possibly resulting from the derivatization process. To define the
Ara branching pattern on the galactan polymer, the per-O-methylated
sample was subjected to time coursemethanolysis followed by re-meth-
ylation. The data generated (Fig. 6B) show numerous partial hydrolytic
products affording informative ion series. A key region of the spectrum
is shown expanded in Fig. 6C, and the assignment of significant prod-
ucts containingRha are presented inTABLEONE.Collectively, the data
indicate that a linear galactan polymer extends from the reducing Rha
and that the first Ara branch appears on the eighth Gal residue with
further Ara branches appearing on the tenth and twelfth Gal residues.
These results are supported by data generated from partial hydrolysis
followed by per-O-deuteromethylation of the resulting hydrolytic prod-
ucts. The mass shifts observed resulting from per-O-deuteromethyla-
tion (data not shown) support the proposed Ara branching pattern.
MALDI MS analysis of per-O-methylated cell walls derived from
C. glutamicum treated with 100 g/ml EMB revealed a similar
profile to that observed for cell walls derived from C. glu-
tamicumemb. In addition, partial hydrolysis confirmed that C. glu-
tamicum treated with EMB produced an AG, which had the same
Ara branching pattern as described above in C. glutamicumemb
(data not shown) illustrating the effects of EMB and emb deletion are
super imposable.
Disruption of Cg-ubiA—Wewere intrigued by UbiA, a putative 4-hy-
droxybenzoate polyprenyltransferase and the possibility that UbiA was
perhaps involved in DPA formation from 5-phosphoribofuranose pyro-
phosphate and decaprenol phosphate. The ubiA gene is present in
FIGURE 5. Glycosyl linkage analysis of per-O-methylated cell walls prepared from
C. glutamicum,C. glutamicumemb, andC. glutamicumembpEKEx2emb.Cellwalls
were prepared as described under “Materials and Methods” per-O-methylated, hydro-
lyzed, reduced, and per-O-acetylated. The resulting partially per-O-methylated, per-O-
acetylated glycosyl derivatives were analyzed by GC/MS as described (6, 7).
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Corynebacterianeae in synteny within the locus of other cell wall-re-
lated genes (Fig. 1B). The orthologue of M. tuberculosis Rv3806c in
C. glutamicum is NCgl2781, and during compilation of this report was
shown biochemically to perform the first step of DPA biosynthesis pro-
ducing decaprenylphosphoryl-5-phosphoribose from 5-phosphoribo-
furanose pyrophosphate and decaprenol phosphate (39). To inactivate
ubiA of C. glutamicum, plasmid pCg::ubiA was constructed and C. glu-
tamicum transformed to kanamycin resistance. The resulting strainwas
confirmed by PCR analysis to have ubiA disrupted. This strain,
C. glutamicum::ubiA was similar to C. glutamicumemb, exhibited
FIGURE 6. MALDI-TOF MS of per-O-methylated cell walls derived from C. glutamicumemb. A, intact per-O-methylated cell walls. B, Per-O-methylated cell walls after partial
hydrolysiswithmethanolicHCl followedby re-methylation.C, the key regionof spectrumBexpandedwith salient signalsunderlined. Signal compositions are assigned in the text. The
100% Sep-Pak fractions are shown. All labeled signals are [MNa].
TABLE ONE
Assignment of the significant partial hydrolytic products detected byMALDI-TOFMS resulting from per-O-methylated cell walls derived from
C. glutamicumemb
m/z Assignmenta m/z Assignmenta m/z Assignmenta
1059 Gal4Rha 2647 AraGal11Rha 3375 Ara3Gal13Rha
1263 Gal5Rha 2807 Ara2Gal11Rha 3419 Ara2Gal14Rha
1467 Gal6Rha 2851 AraGal12Rha 3463 AraGal15Rha
1671 Gal7Rha 3011 Ara2Gal12Rha 3579 Ara3Gal14Rha
2035 AraGal8Rha 3055 AraGal13Rha 3623 Ara2Gal15Rha
2239 AraGal9Rha 3171 Ara3Gal12Rha 3783 Ara3Gal15Rha
2443 AraGal10Rha 3215 Ara2Gal13Rha 4191 Ara3Gal17Rha
2603 Ara2Gal10Rha 3259 AraGal14Rha 4599 Ara3Gal19Rha
a Assignment of Ara, Gal, and Rha based on their identification by linkage analysis.
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poor growth, and was devoid of bound cell wall corynomycolic acids
(data not shown).
Glycosyl Compositional and MALDI MS Analysis of Cell Walls from
C. glutamicum::ubiA—Interestingly, glycosyl compositional analysis
of the resulting cell wall of C. glutamicum::ubiA, in contrast to
C. glutamicumemb, revealed a complete ablation of arabinan (Fig. 7).
The results support a functional role of Cg-ubiA in cell wall arabinan
biosynthesis (39) and demonstrate that DPA is the sole donor of Araf
residues in cell wall biosynthesis in Corynebacterianeae. Analysis of the
per-O-methylated galactan derived form C. glutamicum::ubiA by
MALDIMS revealed a cluster of signals consistent with a galactan back-
bone lacking any t-Ara residues as observed for the emb deletionmutant
(see inset, Fig. 7). The signals atm/z 2895, 3303, 3711, and 4199 can be
assigned the compositions Gal13Rha, Gal15Rha, Gal17Rha, and
Gal19Rha, respectively. The additional signals observed can be assigned
to galactan glycans lackingRha orGal, or retaining theGlcNAc attached
to Rha.
DISCUSSION
The mAGP represents one of the most important cell wall compo-
nents of members of the Corynebacterianeae, and it is essential for the
viability ofM. tuberculosis (27–29). It acts as a fulcrum between pepti-
doglycan and the impermeable hydrophobic mycolic acid layer. Fur-
thermore, its biosynthesis is the target of the anti-mycobacterial drug
EMB. However, the complete biosynthetic pathway and the cellular
machinery involved in AG biosynthesis are still poorly understood (9).
As evident from the genome analyses (Fig. 1A) inMycobacterium and
Corynebacterium species analyzed to date, Cg-emb and its upstream
region is strictly conserved, indicative of a core function common to all
Corynebacterianeae and shown in this study to be involved in the
majority of arabinan deposition in AG. Previous attempts to obtain
embA, embB, and embAB deletionmutants inM. tuberculosis have been
unsuccessful2 and probably reflects the importance of AG in the cell
wall ultrastructure of Mycobacterial species. However, individual dis-
ruptions of embA and embB inM. smegmatis have been obtained result-
ing in viable cells with observable phenotypic alterations to AG (25).
The embA and embB mutants led to an alteration of the terminal Ara6
motif of AG but still produced a highly arabinosylated AGpolymer. The
possibility existed that in either the embA or embB mutant partial
complementation could ensue through the presence of either a func-
tional copy of embA and embB, respectively, as gene duplication and
redundancy appear common inM. tuberculosis (9, 25, 40). As a conse-
quence the isolation of an arabinan-deficient cell wall mutant in
M. tuberculosis appears fraught with difficulty.
With this in mind and because C. glutamicum possesses only a single
emb gene, we attempted to construct an emb deletion mutant of
C. glutamicum. The resultant deletion mutant produced a viable yet
slow growing phenotype with profound morphological changes. Initial
analysis of the corynomycolic acid content of C. glutamicumemb
showed that there was a complete absence of cell wall bound coryno-
mycolates, hinting that there was a loss of corynomycolic acid esterifi-
cation sites in the mutant, consistent with the loss of the terminal Ara6
motif. Upon glycosyl compositional and linkage analysis, we observed in
contrast toM. smegmatis embA and embBmutants (25) a 90% loss of cell
wall arabinan, with all 5-Araf, 3,5-Araf, and 2,5-Araf residues (also
the capping t-Rhap residues) being absent in the cell wall of the
C. glu-tamicumemb, with the relative amounts of Gal unchanged. The
minor amounts of Araf residues were present as t-Araf units. Further-
more, the AG derived from C. glutamicumemb when analyzed by
MALDI-TOFMS and partial acid hydrolysis indicated for the first time
the location of the Ara branches of AG. A linear galactan extends from
the reducing Rha and the first Ara branch appears on the eighth Gal
residue with further Ara branches appearing on the tenth and twelfth
Gal residues (Fig. 8). The observation of t-Araf residues in
FIGURE 7. Analysis of C. glutamicum::ubiA cell walls. Samples of purified cell walls were hydrolyzed with 2 M trifluoroacetic acid, reduced, per-O-acetylated, and subjected to GC
as described under “Materials and Methods” to provide glycosyl compositional analysis. The inset shows the MALDI-TOF MS of per-O-methylated cell walls derived from
C. glutamicum::ubiA.
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C. glutamicumembwas somewhat surprising, because it has long been
thought that the gene products of embA and embB inmycobacterial spp.
are solely responsible for arabinan biosynthesis. Interestingly, the
occurrence of arabinan deposition on an unaffected galactan backbone
suggests that an unidentified arabinofuranosyltransferase might be
responsible for the addition of the initial units onto the galactan domain.
It is tempting to postulate that this hypothetical “priming enzyme”
could fix the initial arabinan units onto the galactan chain for further
elaboration by emb forming the fully matured AG. Interestingly, treat-
ment ofC. glutamicumwith EMB results in a phenotype that is identical
to the C. glutamicumemb, with loss of esterified corynomycolic acids
and a dramatically reduced arabinan content in AG. These results show
that emb is indeed the target for EMB and that the arabinofuranosyl-
transferase activity of the “priming” enzyme remains unaffected. Given
the importance of AG inM. tuberculosis viability and pathogenicity, it is
tempting to suggest that this “priming” enzyme might be an ideal can-
didate to exploit as a drug target, because its disruption would result in
a completely arabinan-deficient cell wall.
Due to the presence of t-Araf residues in the emb-deleted strain of
C. glutamicum, we endeavored to identify genes responsible for DPA
biosynthesis, with the goal of deleting orthologues found in C. glutami-
cum for further phenotypic analysis. This was to rule out the possibility
that the priming enzyme, unlike Emb, which utilizes DPA as a sugar
donor, may use an alternative nucleotide sugar donor (41, 42).
Although the two gene loci depicted in Fig. 1 (A and B) are separated
in M. tuberculosis by only two open reading frames (not shown), this
part is not conserved and is at variance inM. leprae and otherMycobac-
teria. However, genes of the subsequent region extending from accD4 to
glfT are arranged in synteny in all Corynebacterianeae analyzed and are
involved in some aspects of cell wall biosynthesis. For instance, accD4
(accD3 inC. glutamicum), which encodes the-chain of an acyl carbox-
ylase, which together with a second accD orthologue (accD2 in C. glu-
tamicum (31)) and the subsequent pks13 and fadD32, make up the
enzyme complex-activating (43) and -condensing (44) fatty acids, and
these together form mycolic acids in a Claisen condensation reaction.
Further upstream is the mycolyltransferase region (fbpA and fbpC1 of
M. tuberculosis), which is slightly different in C. glutamicum with one
mycolyltransferase, cmytB, possessing a C-terminal extension (45, 46),
and a transposase between the mycolyltransferases. In silico analysis of
the region of genes, which have previously been shown to be involved in
cell wall biosynthesis, resulted in the identification of a putative poly-
prenyltransferase, ubiA. The ubiA gene was found to reside in the
genome of C. glutamicum adjacent to glfT, the gene responsible for
galactan biosynthesis (Fig. 1B), and the region centered around ubiA is
common to all Corynebacterianeae. UbiA is absent in Gram-negative
bacteria and shares high homology with theM. tuberculosis Rv3806c of
53% identity, and interestingly, 49% identity with noeC ofAzorhizobium
caulinodans (47, 48). Recent studies have shown thatUbiA is involved in
the first step of DPA biosynthesis forming decaprenylphosphoryl-5-
phosphoribose from 5-phosphoribofuranose pyrophosphate and deca-
prenol phosphate (39). Directly upstream of ubiA is a gene predicted to
encode a phosphatase, which presumably dephosphorylates decapre-
nylphosphoryl-5-phosphoribose and then is converted to DPA via an
epimerization process.8 The generation of a ubiAmutant ofC. glutami-
cum and chemical analysis of the purified cell wall revealed a complete
loss of arabinan deposition and hence, a viable arabinan-deficient strain
of C. glutamicum. As a result, we have presented unequivocal evidence
that DPA is the only arabinan donor for AG biosynthesis ruling out the
possibility of some other high energy arabinose nucleotide precursor.
These studies also highlight UbiA as a possible drug target due to the
lack of any other compensatory mechanisms to produce DPA and ara-
binan. As a result its disruption would result in a completely arabinan-
deficient cell wall in Corynebacterianeae, such asM. tuberculosis.
In summary, because C. glutamicum and M. tuberculosis share a
common cell wall ultrastructure and biosynthetic machinery, the dele-
tion of emb and disruption of ubiA in C. glutamicum, has allowed us to
shed further light on the role of these genes in cell wall AG biosynthesis
in Corynebacterianeae such asMycobacterium species.
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